GCGabriela Carboni

Gabriela Carboni

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gabriela Carboni has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • MRI risk stratification in metabolic dysfunction–associated steatotic liver disease (MASLD): from diffuse liver disease to focal lesions

    by Gabriela Carboni, Natália Henz Concatto, Rubia Vanceta, Henrique Meira Guerra, Alice Schuch

    Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide. Hepatic steatosis, its imaging hallmark, is a frequent incidental finding in abdominal imaging, often prompting further clinical evaluation. Despite this, the integration of imaging-derived biomarkers into structured risk stratification pathways and longitudinal disease management remains inconsistent in clinical practice. This narrative review outlines the role of multiparametric magnetic resonance imaging (MRI) in the assessment of MASLD, focusing on clinically actionable applications for abdominal radiology. Quantitative MRI biomarkers - including proton density fat fraction (MRI-PDFF), magnetic resonance elastography (MRE), R2* iron quantification, and gadoxetic acid-enhanced MRI - provide complementary information for evaluation of steatosis, fibrosis, iron overload, hepatocellular function, and focal liver lesions. The contribution of multiparametric MRI to opportunistic disease detection, identification of clinically significant fibrosis, and longitudinal monitoring of disease progression and therapeutic response is summarized. Key imaging pitfalls in steatotic livers are addressed, including altered lesion conspicuity, heterogeneous fat and stiffness distribution, focal stiffness abnormalities, and diagnostic challenges related to hepatocellular carcinoma in non-cirrhotic MASLD. Multiparametric MRI enables comprehensive, noninvasive, whole-liver evaluation of MASLD and supports imaging-informed risk stratification and longitudinal disease management in abdominal radiology practice.

  • Imaging of intrauterine contraceptive devices: a comprehensive pictorial review

    by Camila Braga Visconti, Gabriela Carboni, Ariane Giovanaz, Patrícia Valesca Leal, Rubia Vanceta, Alice Schuch, Natália Henz Concatto

    Intrauterine contraceptive devices (IUCDs) are widely used, highly effective, and reversible methods of contraception. Despite their overall safety profile, IUCD malposition and complications May occur and are frequently asymptomatic or clinically unsuspected, posing a diagnostic challenge in daily practice. Imaging plays a central role in evaluating IUCD location, integrity, and associated complications, often in patients undergoing ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) for unrelated indications. Familiarity with the different types of IUCDs and their expected imaging appearances is essential for accurate interpretation. Proper positioning requires complete intrauterine placement with fundal orientation, while deviations May represent a spectrum of malposition, including expulsion, displacement, embedment, and uterine perforation. Additional complications such as fragmentation, missing retrieval strings, pelvic inflammatory disease, actinomycosis, and pregnancy with an IUCD in situ further broaden the differential diagnosis. Recognition of key imaging features and common diagnostic pitfalls is critical, as some findings warrant prompt clinical communication and intervention. Integrating this knowledge into routine imaging assessment enhances diagnostic accuracy, supports appropriate clinical management, and reduces the risk of overlooked IUCD-related complications